Z-2008-2026Class II
Medline Neuro Sponges, various dimensions, labeled as: 1. Neuro Sponges, Eponges neuro, Neuroesponjas, size...
MEDLINE INDUSTRIES, LP - Northfield / initiated 2026-03-19 / Open, Classified / root cause: sterility
Medline Industries, LP began a recall of Medline Neuro Sponges, various dimensions, labeled as: 1. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.25" X 0.25", XR, 10/PK, Medline SKU NEUROSPNG02... on . FDA classified it as Class II and gives the reason as "During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin". As of , the recall status on record is Open, Classified, and MDM tags the root cause as sterility.
Recall record
- Recall number
- Z-2008-2026
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- MEDLINE INDUSTRIES, LP - Northfield
- Product
- Medline Neuro Sponges, various dimensions, labeled as: 1. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.25" X 0.25", XR, 10/PK, Medline SKU NEUROSPNG02; 2. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.5" X 0.5", XR, 10/PK, Medline SKU NEUROSPNG05; 3. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.5" X 1", XR, LF, 10/PK, Medline SKU NEUROSPNG06; 4. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.5" X 1.5", XR, LF, 10/PK, Medline SKU NEUROSPNG07; 5. Neuro Sponges, Eponges neuro, Neuroesponjas, size 0.5" X 3", XR, LF, 10/PK, Medline SKU NEUROSPNG09; 6. Neuro Sponges, Eponges neuro, Neuroesponjas, size .75" X .75", XR, LF, 10/PK, Medline SKU NEUROSPNG11; 7. Neuro Sponges, Eponges neuro, Neuroesponjas, size 1" X 1", XR, LF, 10/PK, Medline SKU NEUROSPNG13; 8. Neuro Sponges, Eponges neuro, Neuroesponjas, size 1" X 3", XR, LF, 10/PK, Medline SKU NEUROSPNG14.
- Product code
- HBA Neurosurgical Paddie
- Reason for recall
- During an internal review, Medline identified higher-than-expected endotoxin levels on a representative Medline neuro sponge product, indicating that in-market product may be out-of-specification for endotoxin.
- Root cause tag
- sterility
- FDA root cause
- Under Investigation by firm
- Action
- Medline industries issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 3/19/2026 via USPS first class mail and email. The notice explained the issue, potential health risk, and requested the following actions be taken on the affected sponges: Identify and quarantine affected product, complete response form using website link: https://recalls.medline.com, destroy affected product. Credit will be issued once response form is received. If the product has been further distributed, sold, or transferred, notify the customer to destroy the product. Distributors must notify their customers and should include customer quantities on your response form. For consignees of Medline medical convenience kits containing the affected sponges the actions to be taken are as follows: Identify and quarantine all affected kits, complete response form using website link: https://recalls.medline.com. Upon receipt of your submitted response form, your account will receive over-labels to place on affected inventory, with instructions for your staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. Distributors must notify their customers and should include customer quantities on your response form. Upon receipt of your submitted response form, you will receive over-labels to provide to your customers to affix to their affected product. If you have any questions, contact the Recall Department at 866-359-1704 or [email protected].
- Quantity in commerce
- 4225160 units
- Distribution
- Worldwide distribution.
- Product codes and lots
- 1. NEUROSPNG02: UDI/DI each 10197344111572, UDI/DI case 20197344111579, ALL LOTS; 2. NEUROSPNG05: UDI/DI each 20080196286659, UDI/DI case 30080196286656, ALL LOTS; 3. NEUROSPNG06: UDI/DI each 20080196286505, UDI/DI case 30080196286502, ALL LOTS; 4. NEUROSPNG07: UDI/DI each 10080196286485, UDI/DI case 40080196286486, ALL LOTS; 5. NEUROSPNG09: UDI/DI each 20080196286536, UDI/DI case 30080196286533, ALL LOTS; 6. NEUROSPNG11: UDI/DI each 20080196286550, UDI/DI case 30080196286557, ALL LOTS; 7. NEUROSPNG13: UDI/DI each 10080196286577, UDI/DI case 40080196286578, ALL LOTS; 8. NEUROSPNG14: UDI/DI each 10080196286584, UDI/DI case 40080196286585, ALL LOTS.
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2008-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2009-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2010-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2011-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2012-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2013-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2014-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2015-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2016-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2017-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2018-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2019-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2020-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2021-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2022-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2023-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2024-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2025-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2026-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2027-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2028-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2029-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2030-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2031-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2032-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2033-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2034-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2035-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2036-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2037-2026 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-2038-2026 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.